UBS Group’s ETRACS 2x Leveraged US Size Factor TR ETN IWML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-38,444
Closed -$1.18M – 11422
2026
Q2
$1.18M Buy
38,444
+28,649
+292% +$853K ﹤0.01% 5577
2026
Q1
$227K Buy
9,795
+9,773
+44,423% +$248K ﹤0.01% 6563
2025
Q4
$516 Buy
+22
New +$514 ﹤0.01% 9919
2025
Q3
– Sell
-182
Closed -$3.38K – 10606
2025
Q2
$3.38K Buy
182
+145
+392% +$2.38K ﹤0.01% 9361
2025
Q1
$631 Buy
+37
New +$758 ﹤0.01% 9705
2024
Q4
– Sell
-2,188
Closed -$47.3K – 10170
2024
Q3
$47.3K Buy
2,188
+2,135
+4,028% +$43.5K ﹤0.01% 6850
2024
Q2
$980 Buy
+53
New +$977 ﹤0.01% 8710
2024
Q1
– Sell
-2,990
Closed -$55.3K – 9681
2023
Q4
$55.3K Buy
+2,990
New +$44.7K ﹤0.01% 6480
2022
Q3
– Sell
-29
Closed – – 10623
2022
Q2
$0 Buy
+29
New +$505 ﹤0.01% 10620

UBS Group's IWML Position: Q3 2026 in Review

UBS Group sold out of ETRACS 2x Leveraged US Size Factor TR ETN (IWML) in Q3 2026, closing a stake of 38,444 shares — an estimated $1.18M sold.

UBS Group first reported a position in IWML in Q2 2022 and held it in 9 quarters. The position peaked at $1.18M in Q2 2026. 0 funds tracked by Wall St. Rank hold IWML as of Q3 2026.

  • UBS Group reported no remaining ETRACS 2x Leveraged US Size Factor TR ETN position as of Q3 2026 after selling out during the quarter.
  • UBS Group sold 38,444 ETRACS 2x Leveraged US Size Factor TR ETN shares in Q3 2026, an estimated $1.18M.
  • UBS Group first reported a position in ETRACS 2x Leveraged US Size Factor TR ETN in Q2 2022 and held it in 9 quarters.
  • UBS Group's ETRACS 2x Leveraged US Size Factor TR ETN position peaked at $1.18M in Q2 2026.
  • 0 funds tracked by Wall St. Rank held ETRACS 2x Leveraged US Size Factor TR ETN as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.